Spectral Medical (TSE:EDT) Issues Quarterly Earnings Results

Spectral Medical (TSE:EDT) released its earnings results on Thursday. The company reported C($0.01) earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of C$0.38 million for the quarter.

Spectral Medical Stock Performance

TSE EDT opened at C$1.43 on Friday. Spectral Medical has a 1-year low of C$0.66 and a 1-year high of C$1.84. The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03. The company has a market capitalization of C$413.47 million, a PE ratio of -10.21 and a beta of 0.63. The firm’s fifty day simple moving average is C$1.33 and its 200-day simple moving average is C$1.39.

About Spectral Medical

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.